AFIB vs. VERO, TMDIF, STSS, IONM, AVGR, AEMD, GMVDF, UTRS, INVO, and OSA
Should you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Venus Concept (VERO), Titan Medical (TMDIF), Sharps Technology (STSS), Assure (IONM), Avinger (AVGR), Aethlon Medical (AEMD), G Medical Innovations (GMVDF), Minerva Surgical (UTRS), INVO Bioscience (INVO), and ProSomnus (OSA). These companies are all part of the "surgical & medical instruments" industry.
Venus Concept (NASDAQ:VERO) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, community ranking, media sentiment and profitability.
Venus Concept has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Acutus Medical has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.
Venus Concept received 22 more outperform votes than Acutus Medical when rated by MarketBeat users. Likewise, 65.38% of users gave Venus Concept an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote.
87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 51.4% of Venus Concept shares are owned by company insiders. Comparatively, 3.5% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, Acutus Medical had 2 more articles in the media than Venus Concept. MarketBeat recorded 5 mentions for Acutus Medical and 3 mentions for Venus Concept. Acutus Medical's average media sentiment score of 0.46 beat Venus Concept's score of 0.14 indicating that Venus Concept is being referred to more favorably in the media.
Venus Concept has a net margin of -48.79% compared to Venus Concept's net margin of -166.79%. Acutus Medical's return on equity of 0.00% beat Venus Concept's return on equity.
Venus Concept has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks.
Summary
Venus Concept beats Acutus Medical on 11 of the 15 factors compared between the two stocks.
Get Acutus Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Acutus Medical Competitors List
Related Companies and Tools
